Skip to main content

Stockpile (medical supplies, PPE, etc) (COVID-19)

Made in Canada Project

  • The Made in Canada Project is the result of the federal government's call to action at the beginning of the COVID-19 pandemic to mobilize Canadian businesses and manufacturers in supplying essential materials to combat this public health crisis.
  • This page includes what companies have done to adjust to the pandemic, videos on their efforts, how these businesses have been supported, and details on the Canadian research projects conducted throughout COVID-19.

National Emergency Strategic Stockpile

  • This page examines the Canada's National Emergency Strategic Stockpile (NESS), which is maintained by the Public Health Agency of Canada and is intended to provide additional supplies to the provinces and territories during emergency situations.
  • The supplies can include medical equipment/supplies, pharmaceuticals, and social service supplies like beds and blankets.
  • The NESS was

COVID-19 and Trade: Needed Medical Goods

  • During the beginning of the pandemic, countries around the world, including Canada, faced a shortage of vital medical supplies such as ventilators and personal protective equipment such as face masks, respirators, gloves, goggles, and garments.
  • This document explores the different approaches countries took to restrict the exportation of COVID-19 related goods and the affects the pandemic had on trade more generally.

Procuring COVID-19 Supplies

  • This page discusses the federal government's investments in research, science, and innovation to increase supply of medical equipment for the health care system during COVID-19.
  • Further, this page outlines the federal, provincial, and territorial efforts, an overview of purchases and deliveries, and how domestic Canadian companies have helped in this effort. 

COVID-19 Research and Development

  • This pronouncement made by Justin Trudeau addresses the $1+ billion federal funding for medical research and vaccine development in response to COVID-19, which builds upon the $275 million that was announced in March 2020.
  • This funding will go towards the supporting the mobilization of a COVID-19 Immunity Task Force, the Canadian COVID-19 Genomics Network, the Vaccine and Infectious Disease Organization-International Vaccine Centre, the National Research Council o